Reexpression of normal stem cells in erythroleukemia during remission

A. M. Ferraris, L. Canepa, C. Mareni, G. Baule, T. Meloni, E. Salvidio, G. Forteleoni, G. F. Gaetani

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

A patient with erythroleukemia and heterozygous for the Mediterranean variant of the X-linked enzyme glucose-6-phosphate dehydrogease (G6PD) was studied to determine the number and type of progenitor cells in which the disease arose. G6PD mosaicism was assessed by the different rate of utilization of 2-deoxy-glucose-6-phosphate (2dG6P) by normal and Mediterranean variants of G6PD. Erythroleukemia is established as a clonal disease involving a precursor cell common to the erythroid and myeloid lines. After intensive chemotherapy, restoration of nonmonoclonal hemopoiesis is achieved, as indicated by the reappearance of the mosaic phenotype in hemopoeitic cell populations.

Original languageEnglish
Pages (from-to)177-179
Number of pages3
JournalBlood
Volume62
Issue number1
Publication statusPublished - 1983

Fingerprint

Leukemia, Erythroblastic, Acute
Glucose-6-Phosphate
Stem cells
Stem Cells
Mosaicism
Chemotherapy
Restoration
Cells
Phenotype
Drug Therapy
Enzymes
Population

ASJC Scopus subject areas

  • Hematology

Cite this

Ferraris, A. M., Canepa, L., Mareni, C., Baule, G., Meloni, T., Salvidio, E., ... Gaetani, G. F. (1983). Reexpression of normal stem cells in erythroleukemia during remission. Blood, 62(1), 177-179.

Reexpression of normal stem cells in erythroleukemia during remission. / Ferraris, A. M.; Canepa, L.; Mareni, C.; Baule, G.; Meloni, T.; Salvidio, E.; Forteleoni, G.; Gaetani, G. F.

In: Blood, Vol. 62, No. 1, 1983, p. 177-179.

Research output: Contribution to journalArticle

Ferraris, AM, Canepa, L, Mareni, C, Baule, G, Meloni, T, Salvidio, E, Forteleoni, G & Gaetani, GF 1983, 'Reexpression of normal stem cells in erythroleukemia during remission', Blood, vol. 62, no. 1, pp. 177-179.
Ferraris AM, Canepa L, Mareni C, Baule G, Meloni T, Salvidio E et al. Reexpression of normal stem cells in erythroleukemia during remission. Blood. 1983;62(1):177-179.
Ferraris, A. M. ; Canepa, L. ; Mareni, C. ; Baule, G. ; Meloni, T. ; Salvidio, E. ; Forteleoni, G. ; Gaetani, G. F. / Reexpression of normal stem cells in erythroleukemia during remission. In: Blood. 1983 ; Vol. 62, No. 1. pp. 177-179.
@article{48f33b80b0b24d27962de70f463ffe4c,
title = "Reexpression of normal stem cells in erythroleukemia during remission",
abstract = "A patient with erythroleukemia and heterozygous for the Mediterranean variant of the X-linked enzyme glucose-6-phosphate dehydrogease (G6PD) was studied to determine the number and type of progenitor cells in which the disease arose. G6PD mosaicism was assessed by the different rate of utilization of 2-deoxy-glucose-6-phosphate (2dG6P) by normal and Mediterranean variants of G6PD. Erythroleukemia is established as a clonal disease involving a precursor cell common to the erythroid and myeloid lines. After intensive chemotherapy, restoration of nonmonoclonal hemopoiesis is achieved, as indicated by the reappearance of the mosaic phenotype in hemopoeitic cell populations.",
author = "Ferraris, {A. M.} and L. Canepa and C. Mareni and G. Baule and T. Meloni and E. Salvidio and G. Forteleoni and Gaetani, {G. F.}",
year = "1983",
language = "English",
volume = "62",
pages = "177--179",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Reexpression of normal stem cells in erythroleukemia during remission

AU - Ferraris, A. M.

AU - Canepa, L.

AU - Mareni, C.

AU - Baule, G.

AU - Meloni, T.

AU - Salvidio, E.

AU - Forteleoni, G.

AU - Gaetani, G. F.

PY - 1983

Y1 - 1983

N2 - A patient with erythroleukemia and heterozygous for the Mediterranean variant of the X-linked enzyme glucose-6-phosphate dehydrogease (G6PD) was studied to determine the number and type of progenitor cells in which the disease arose. G6PD mosaicism was assessed by the different rate of utilization of 2-deoxy-glucose-6-phosphate (2dG6P) by normal and Mediterranean variants of G6PD. Erythroleukemia is established as a clonal disease involving a precursor cell common to the erythroid and myeloid lines. After intensive chemotherapy, restoration of nonmonoclonal hemopoiesis is achieved, as indicated by the reappearance of the mosaic phenotype in hemopoeitic cell populations.

AB - A patient with erythroleukemia and heterozygous for the Mediterranean variant of the X-linked enzyme glucose-6-phosphate dehydrogease (G6PD) was studied to determine the number and type of progenitor cells in which the disease arose. G6PD mosaicism was assessed by the different rate of utilization of 2-deoxy-glucose-6-phosphate (2dG6P) by normal and Mediterranean variants of G6PD. Erythroleukemia is established as a clonal disease involving a precursor cell common to the erythroid and myeloid lines. After intensive chemotherapy, restoration of nonmonoclonal hemopoiesis is achieved, as indicated by the reappearance of the mosaic phenotype in hemopoeitic cell populations.

UR - http://www.scopus.com/inward/record.url?scp=0020621163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020621163&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 177

EP - 179

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -